Replies to post #307850 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

On the ???s of patentabilities

Targeting was obvious IMHO. Anexin V does that, but wasn't that only to see the PS for Apoptosis reasons...just measuring PS exposure.

Targeting to effect PS signaling pathways is the new and important part. I HOPE!

ALSO, the ~30 hour duration of the binding affinity is new. Correct?

Is this a viable angle for patentability in your professional opinion?

wook